301 related articles for article (PubMed ID: 26307090)
1. In silico and in vitro methods to optimize the performance of experimental gastroretentive floating mini-tablets.
Eberle VA; Häring A; Schoelkopf J; Gane PA; Huwyler J; Puchkov M
Drug Dev Ind Pharm; 2016; 42(5):808-17. PubMed ID: 26307090
[TBL] [Abstract][Full Text] [Related]
2. Floating gastroretentive drug delivery systems: Comparison of experimental and simulated dissolution profiles and floatation behavior.
Eberle VA; Schoelkopf J; Gane PA; Alles R; Huwyler J; Puchkov M
Eur J Pharm Sci; 2014 Jul; 58():34-43. PubMed ID: 24704154
[TBL] [Abstract][Full Text] [Related]
3. QbD-Oriented Development and Characterization of Effervescent Floating-Bioadhesive Tablets of Cefuroxime Axetil.
Bansal S; Beg S; Garg B; Asthana A; Asthana GS; Singh B
AAPS PharmSciTech; 2016 Oct; 17(5):1086-99. PubMed ID: 26527606
[TBL] [Abstract][Full Text] [Related]
4. Development of Multiple-Unit Floating Drug Delivery System of Clarithromycin: Formulation, in vitro Dissolution by Modified Dissolution Apparatus, in vivo Radiographic Studies in Human Volunteers.
Reddy AB; Reddy ND
Drug Res (Stuttg); 2017 Jul; 67(7):412-418. PubMed ID: 28449156
[TBL] [Abstract][Full Text] [Related]
5. A novel automated alternating current biosusceptometry method to characterization of controlled-release magnetic floating tablets of metronidazole.
Ferrari PC; dos Santos Grossklauss DB; Alvarez M; Paixão FC; Andreis U; Crispim AG; de Castro AD; Evangelista RC; de Arruda Miranda JR
Drug Dev Ind Pharm; 2014 Aug; 40(8):1123-31. PubMed ID: 23815300
[TBL] [Abstract][Full Text] [Related]
6. Development of gastroretentive drug delivery system for cefuroxime axetil: in vitro and in vivo evaluation in human volunteers.
Bomma R; Veerabrahma K
Pharm Dev Technol; 2013; 18(5):1230-7. PubMed ID: 22348334
[TBL] [Abstract][Full Text] [Related]
7. Design and optimization of gastric floating sustained-release mini-tablets of alfuzosin hydrochloride based on a factorial design: in vitro/in vivo evaluation.
Gong L; Yu M; Sun Y; Gao Y; An T; Zou M; Cheng G
Drug Dev Ind Pharm; 2018 Dec; 44(12):1990-1999. PubMed ID: 30058391
[TBL] [Abstract][Full Text] [Related]
8. Development and Optimization of Methscopolamine Bromide Gastroretentive Floating Tablets Using 32 Factorial Design.
Singh MP; Kumar M; Shankar R
Drug Res (Stuttg); 2020 Dec; 70(12):576-582. PubMed ID: 32992345
[TBL] [Abstract][Full Text] [Related]
9. Preparation and pharmacokinetics study on gastro-floating sustained-release tablets of troxipide.
Gao Y; Gao Y; Yin F; Wang M; Wang Z; Ye T; Yang Y; Pan WS; Yang X
Drug Dev Ind Pharm; 2015; 41(9):1443-51. PubMed ID: 25190152
[TBL] [Abstract][Full Text] [Related]
10. Design and evaluation of floating multi-layer coated tablets based on gas formation.
Sungthongjeen S; Sriamornsak P; Puttipipatkhachorn S
Eur J Pharm Biopharm; 2008 May; 69(1):255-63. PubMed ID: 17967527
[TBL] [Abstract][Full Text] [Related]
11. Release kinetics of highly porous floating tablets containing cilostazol.
Hwang KM; Cho CH; Tung NT; Kim JY; Rhee YS; Park ES
Eur J Pharm Biopharm; 2017 Jun; 115():39-51. PubMed ID: 28219750
[TBL] [Abstract][Full Text] [Related]
12. Formulation and in-vitro evaluation of floating bilayer tablet of lisinopril maleate and metoprolol tartrate.
Ijaz H; Qureshi J; Danish Z; Zaman M; Abdel-Daim M; Hanif M; Waheed I; Mohammad IS
Pak J Pharm Sci; 2015 Nov; 28(6):2019-25. PubMed ID: 26639495
[TBL] [Abstract][Full Text] [Related]
13. DDSolver Software Application for Quantitative Analysis of In vitro Drug Release Behavior of the Gastroretentive Floating Tablets Combined with Radiological Study in Rabbits.
Abdul Rasool BK; Sammour R
Curr Drug Deliv; 2022 Aug; 19(9):949-965. PubMed ID: 35249487
[TBL] [Abstract][Full Text] [Related]
14. Development of sustained release floating drug delivery system for norfloxacin: in vitro and in vivo evaluation.
Guguloth M; Bomma R; Veerabrahma K
PDA J Pharm Sci Technol; 2011; 65(3):198-206. PubMed ID: 22293231
[TBL] [Abstract][Full Text] [Related]
15. Physiological relevant in vitro evaluation of polymer coats for gastroretentive floating tablets.
Eisenächer F; Garbacz G; Mäder K
Eur J Pharm Biopharm; 2014 Nov; 88(3):778-86. PubMed ID: 25086221
[TBL] [Abstract][Full Text] [Related]
16. Design and optimization of gastro-floating sustained-release tablet of pregabalin: In vitro and in vivo evaluation.
Qin C; Wu M; Xu S; Wang X; Shi W; Dong Y; Yang L; He W; Han X; Yin L
Int J Pharm; 2018 Jul; 545(1-2):37-44. PubMed ID: 29649518
[TBL] [Abstract][Full Text] [Related]
17. Interaction between fed gastric media (Ensure Plus®) and different hypromellose based caffeine controlled release tablets: comparison and mechanistic study of caffeine release in fed and fasted media versus water using the USP dissolution apparatus 3.
Franek F; Holm P; Larsen F; Steffansen B
Int J Pharm; 2014 Jan; 461(1-2):419-26. PubMed ID: 24342711
[TBL] [Abstract][Full Text] [Related]
18. Effect of formulation parameters on the drug release and floating properties of gastric floating two-layer tablets with acetylsalicylic acid.
Hasçiçek C; Yüksel-Tilkan G; Türkmen B; Ozdemir N
Acta Pharm; 2011 Sep; 61(3):303-12. PubMed ID: 21945909
[TBL] [Abstract][Full Text] [Related]
19. Mini-tablets: a contemporary system for oral drug delivery in targeted patient groups.
Aleksovski A; Dreu R; Gašperlin M; Planinšek O
Expert Opin Drug Deliv; 2015 Jan; 12(1):65-84. PubMed ID: 25200881
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of drug release from aged prolonged polyethylene oxide tablet matrices: effect of excipient and drug type.
Shojaee S; Kaialy W; Cumming KI; Nokhodchi A
Pharm Dev Technol; 2016 Mar; 21(2):189-95. PubMed ID: 25410967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
